APP and Alzheimer disease: For example, circRNA ciRS-7 has shown to bind miR-7 to degrade β-amyloid precursor protein (APP) and β-site APP cleaving enzyme 1 (BACE1), thus ciRS-7 may be a useful target in developing therapeutic strategies for AD [8].